查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1949077

全球個人化醫療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Personalized Medicine Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計個人化醫療市場將從 2025 年的 5,082.7 億美元成長到 2034 年的 1,8,048.8 億美元，2026 年至 2034 年的複合年成長率為 15.12%。

基因組學和生物技術的進步正在推動個人化醫療解決方案的發展，個人化醫療市場預計將迎來顯著成長。個人化醫療是指根據個體的特徵（例如遺傳特徵、生活方式和環境因素）來客製化治療方案。慢性病發病率的上升以及對標靶治療需求的成長正在推動對個人化醫療的投資，並進一步擴大市場規模。此外，對改善患者預後和降低醫療成本的關注也促進了個人化治療方法的應用。

技術創新在塑造個人化醫療市場的未來方面發揮著至關重要的作用。基因組學、生物資訊學和數據分析領域的創新正在增強識別特定生物標記和開發標靶治療的能力。此外，人工智慧和機器學習的整合使醫療服務提供者能夠分析大量數據，並就治療方案做出明智的決策。隨著行業的不斷發展，預計個人化醫療市場將在各種醫療環境中更廣泛地採用技術主導的解決方案。

此外，對病患參與和教育的日益重視也影響著個人化醫療市場的發展軌跡。隨著患者對自身健康狀況和治療方案的了解不斷加深，他們對能夠滿足個別需求的個人化解決方案的需求也日益成長。這一趨勢正在推動醫療服務提供者、製藥公司和科技公司之間的合作，並加速開發能夠賦能患者積極參與自身醫療決策的教育資源和支持系統。隨著市場的不斷發展，科技的應用、病人參與以及個人化醫療的整合將是成功的關鍵。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球個人化醫療市場：依產品類型分類

  • 市場分析、洞察與預測
  • 診斷
  • 治療
  • 個人化醫療
  • 其他

第5章：全球個人化醫療市場：依應用領域分類

  • 市場分析、洞察與預測
  • 腫瘤學
  • 心臟病學
  • 神經病學
  • 感染疾病
  • 其他

第6章：全球個人化醫療市場：依技術分類

  • 市場分析、洞察與預測
  • 基因組學
  • 藥物基因體學
  • 伴隨診斷
  • 其他

第7章 全球個人化醫療市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 診斷中心
  • 研究所
  • 其他

第8章：全球個人化醫療市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Roche
    • Thermo Fisher Scientific
    • Illumina
    • GE Healthcare
    • Abbott Laboratories
    • Danaher Corporation
    • Qiagen
    • Agilent Technologies
    • Bio-Rad Laboratories
    • Hologic
    • Exact Sciences
    • PerkinElmer
    • Myriad Genetics
    • Foundation Medicine
    • Invitae Corporation
簡介目錄
Product Code: VMR11219103

The Personalized Medicine Market size is expected to reach USD 1804.88 Billion in 2034 from USD 508.27 Billion (2025) growing at a CAGR of 15.12% during 2026-2034.

The Personalized Medicine Market is poised for significant growth as advancements in genomics and biotechnology enable tailored healthcare solutions. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetic makeup, lifestyle, and environmental factors. The increasing prevalence of chronic diseases and the growing demand for targeted therapies are driving investments in personalized medicine, further propelling market expansion. Additionally, the emphasis on improving patient outcomes and reducing healthcare costs is contributing to the adoption of personalized approaches in treatment.

Technological advancements are playing a crucial role in shaping the future of the personalized medicine market. Innovations in genomic sequencing, bioinformatics, and data analytics are enhancing the ability to identify specific biomarkers and develop targeted therapies. Furthermore, the integration of artificial intelligence and machine learning is enabling healthcare providers to analyze vast amounts of data and make informed decisions regarding treatment options. As the industry continues to evolve, the personalized medicine market is likely to see increased adoption of technology-driven solutions across various healthcare settings.

Moreover, the growing emphasis on patient engagement and education is influencing the personalized medicine market's growth trajectory. As patients become more informed about their health and treatment options, there is a rising demand for personalized solutions that cater to their specific needs. This trend is driving collaboration between healthcare providers, pharmaceutical companies, and technology firms to develop educational resources and support systems that empower patients to take an active role in their healthcare decisions. As the market continues to evolve, the integration of technology, patient engagement, and personalized care will be key drivers of success.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

  • Diagnostics
  • Therapeutics
  • Personalized Medical Care
  • Others

By Application

  • Oncology
  • Cardiology
  • Neurology
  • Infectious Diseases
  • Others

By Technology

  • Genomics
  • Pharmacogenomics
  • Companion Diagnostics
  • Others

By End-User

  • Hospitals
  • Diagnostic Centers
  • Research Laboratories
  • Others

COMPANIES PROFILED

  • Roche, Thermo Fisher Scientific, Illumina, GE Healthcare, Abbott Laboratories, Danaher Corporation, Qiagen, Agilent Technologies, BioRad Laboratories, Hologic, Exact Sciences, PerkinElmer, Myriad Genetics, Foundation Medicine, Invitae Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PERSONALIZED MEDICINE MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product Type
  • 4.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Personalized Medical Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PERSONALIZED MEDICINE MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PERSONALIZED MEDICINE MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Technology
  • 6.2. Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Pharmacogenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Companion Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PERSONALIZED MEDICINE MARKET: BY END-USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End-user
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Research Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PERSONALIZED MEDICINE MARKET: BY REGION 2022-2034(USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Product Type
    • 8.2.2 By Application
    • 8.2.3 By Technology
    • 8.2.4 By End-user
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Product Type
    • 8.3.2 By Application
    • 8.3.3 By Technology
    • 8.3.4 By End-user
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Product Type
    • 8.4.2 By Application
    • 8.4.3 By Technology
    • 8.4.4 By End-user
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Product Type
    • 8.5.2 By Application
    • 8.5.3 By Technology
    • 8.5.4 By End-user
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 South East Asia
    • 8.5.10 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Product Type
    • 8.6.2 By Application
    • 8.6.3 By Technology
    • 8.6.4 By End-user
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL PERSONALIZED MEDICINE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Roche
    • 10.2.2 Thermo Fisher Scientific
    • 10.2.3 Illumina
    • 10.2.4 GE Healthcare
    • 10.2.5 Abbott Laboratories
    • 10.2.6 Danaher Corporation
    • 10.2.7 Qiagen
    • 10.2.8 Agilent Technologies
    • 10.2.9 Bio-Rad Laboratories
    • 10.2.10 Hologic
    • 10.2.11 Exact Sciences
    • 10.2.12 PerkinElmer
    • 10.2.13 Myriad Genetics
    • 10.2.14 Foundation Medicine
    • 10.2.15 Invitae Corporation